LATEST ALERTS
Sports governing bodies are slowly beginning to change their drug policies on CBD in response to evolving attitudes, more than a year after the World Anti-Doping Agency (WADA) first allowed its use
Legal advice, insurance and compliance with consumer protection law could all help CBD companies minimise their exposure to what appears to be a rising tide of lawsuits and FDA warnings
A tax break given to a new CBD oil processing plant demonstrates that the industry is being taken seriously enough at local government level in the US to negotiate tax breaks like any other potential employers
While figures show China has around half the agricultural land in the world under hemp cultivation, the CBD industry in the nation is really only just beginning, according to experts at a recent conference
The proposal to regulate and tax low-THC hemp varieties of cannabis has been removed from the budget bill and declared inadmissible by the president of the Italian senate
Regulation in Belgium and possibly across Europe may change as a result of the link being made between CBD vaping and a teenager’s death – though that link has not been verified
The legalisation of cannabis production in Zimbabwe – including both low-THC “hemp” and higher THC “medical cannabis” varieties – has created considerable interest but continues to be held back
Guidance on SAFE Banking, the emergence of non-CBD CBD creams, and a question of wind in Arizona are among the latest items of business news in brief from CBD-Intel
Boris Johnson’s landslide victory in the British general election means Brexit will almost certainly take place early in 2020. But will the strenthening of the Conservative grip on power have any direct impact on CBD?
The organisers of Hemp and CBD Expo invited our MD, Tim Phillips, to participate in their round table about Brexit. Their aim was to objectively understand what the Brexit impacts are going to be over the next few years for CBD and the UK CBD industry. Don’t miss out on this interesting debate. If you […]
Scrutiny of the CBD market appears to be growing at the US Food and Drug Administration (FDA), which this week reprimanded a further 15 companies for selling CBD products as drugs and also updated its advice to consumers on potential dangers
CBD-Intel’s regular podcasts provide expert insight into global regulation, market trends and the latest developments. Join us to find out more about this fast-moving industry with the CBD-Intel team. Thanks for listening!
A Senate vote in Mexico on legalising cannabis has been postponed. In Germany, three hemp shops have been raided on suspicion of breaking narcotics and pharmaceuticals laws. These and other stories from the US, Asia and Paraguay
The Centre for Medical Cannabis is launching a new Association for the Cannabinoid Industry (ACI), claiming to be the first CBD trade organisation in the UK to ensure compliance with EU novel food regulations
Little is expected to change at the US FDA in terms of CBD or cannabis policy if president Donald Trump’s nominee Stephen Hahn is approved as commissioner, according to sources contacted by CBD-Intel
According to research from San Diego State University, CBD is the most searched health term in the US. Also covered are further stories from the US, Australia, India, Italy and Switzerland
The legalisation of medical cannabis in Ukraine, which was expected this year, is now likely to be indefinitely suspended following a decision not to include cannabis in the list of substances permitted in the country
Companies can advertise food and drinks as containing CBD, however, they should be careful about implying any link to illicit drugs like cannabis, according to the UK Advertising Standards Authority (ASA)
Leading CBD sellers in the US have been urged to clean up their act by the Center for Food Safety (CFS) after a “scorecard” survey revealed supply chain failings – from farm to point of sale
Funding success for new developments in hemp research, as well as innovations such as monitoring the path of pollen using drones
CBD-Intel brings you business and related news in brief from the US, China, Israel and UK
Despite various bodies making steps towards legalisation, the existing legal environment for CBD across the US remains a patchwork of contradictory policies
Passage of the Secure and Fair Enforcement (SAFE) Banking Act through the US House of Representatives is but one skirmish, with a potentially fiercer battle awaiting in the Senate and the White House
As Canada prepares for the legalisation of cannabis edibles and topical creams this autumn, one province wants to restrict them. Quebec has served notice that it plans to adopt its own set of regulations banning cannabis-laced edibles that might appeal to youth.
Experts have criticised plans by the Irish government to turn the country’s dwindling peat bogs into hemp farms that could produce the raw material for CBD products
Regulatory developments from the US, EU, Germany, Italy, India, Israel and Myanmar – and news of an “illegal” incursion into Austria by undercover Swiss border guards
The chief medical officer of the US National Football League (NFL) remains wary of letting players use CBD, despite a number of stars coming forward to endorse it
In our look at the regulatory picture in India we find that while CBD is regulated at a federal level, states also have their own rules and regulations with some more lenient than others
South Dakota governor Kristi Noem has explained why she continues to oppose hemp legalisation in the state; Flanders in Belgium is seeing enforcement action against CBD shops because of CBD oils and teas; Australian state Victoria may yet see hemp farming legalised as attitudes appear to be softening; and much more…
The launch of many CBD-containing foods, beverages and cosmetics in California has been delayed further as a bill legalising their sale is now not expected to pass before the end of the legislative session, which ends on on 13th September
Americans for Safe Access has issued the Patient’s Guide to CBD, Ireland sees increase in hemping-growing licence applications, and over 6000 plants have been seized in Portugal
Austrian and German police policy, local THC decision in Italy, Slovakian de-scheduling, Croatian proposals, US federal and state rulings and Israeli priorities come under the regulatory spotlight
Consumers looking for the medical benefits of cannabis are willing to pay a premium for high-CBD flowers, according to the findings of a new study by a group of US universities
CBD supplier Kannaway says it has been granted licences confirming compliance with the law and permitting free sale of a product in an EU member state – Bulgaria – as well as in Russia
The precise role Mexico’s government should play in a future cannabis industry was among the major issues discussed at a recent three-day event hosted by the country’s Senate
CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey
The panel responsible for recommending which drugs England’s National Health Service (NHS) should prescribe may recommend against the organisation using cannabis-based medical products.
The latest news and developments in the CBD industry worldwide rounded up in CBD-Intel’s weekly News In Brief.
CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and Zimbabwe
CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa
A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European Union.
Many US senators seem ready to pass a law allowing financial institutions to work with CBD businesses. That’s if a hearing on the SAFE Banking Act is any indication
The US Food and Drug Administration (FDA)’s request for comments on regulating cannabis-related products drew 4492 responses covering a dizzying array of views
CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium
CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China
While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction
Attention in Washington is increasingly focused on CBD, with the US Congress striving to address regulation and the FDA promising policy action soon
CBD has turned Washington upside down, with a legal expert at the conservative Heritage Foundation testifying to Congress on behalf of federalism over states’ rights and free enterprise
CBD-Intel brings you regulatory updates from Italy, France, Turkey, New Zealand, El Salvador, the US states of Delaware and South Dakota and the island territory of Guam
The UK Centre for Medical Cannabis (CMC) has called for a Cannabinoid Clinical Trials Authority to regulate and test cannabis-based medicinal products
Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
